Home India Ministry of Health and Family Welfare Parliament Question: Surge in respiratory medicine sales and...
Date: 2026-02-10 Category: RAJYASABHA_QNA State: Union Government Country: India

Parliament Question: Surge in respiratory medicine sales and public health impact of air pollution

Issued by Ministry of Health and Family Welfare · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task
Official Source Record View Original Source →
See Full Document Text
GOVERNMENTOFINDIA MINISTRYOFHEALTH AND FAMILYWELFARE DEPARTMENTOFHEALTH AND FAMILYWELFARE RAJYASABHA UNSTARREDQUESTION NO. 1208 TO BE ANSWERED ON10THFEBRUARY, 2026 SURGE IN RESPIRATORYMEDICINESALES ANDPUBLIC HEALTH IMPACT OFAIR POLLUTION 1208Ms. SUSHMITADEV: Will the Ministerof HEALTH AND FAMILYWELFAREbe pleasedtostate: (a) whether Government has taken note of reports indicating a record surge in sales of respiratory medicines, crossing ₹1,950 crore in December 2025, with sustained year-on year increasesduring high-pollutionmonths; (b) whether Government acknowledges that such sharp increases in sales of anti-asthma, Chronic Obstructive Pulmonary Disease (COPD) and allergy medications reflecta worsening air-pollution-linked public healthburdenratherthanmere seasonal illness; (c) whether any official study or epidemiological assessment has been conducted to establish a direct correlation between air pollution levels and rising respiratory morbidity and deaths; and (d) the number of pollution-related respiratory illnesses and deaths reported annually during the last five years, State-wise? ANSWER THE MINISTER OFSTATE IN THE MINISTRYOFHEALTH AND FAMILY WELFARE (SMT.ANUPRIYAPATEL) (a)to(d): As informed by the Department of Pharmaceuticals, based on the market data available with the National Pharmaceutical Pricing Authority (NPPA) through the Pharmarack database, the sales values of medicines (both scheduled and non-scheduled formulations) pertaining to the therapeutic category “Respiratory System” for the month of December2025is₹1952.92 crore.And the yearonyear sales value isasfollows: Month Total sales value in2024 (₹crore) Total sales value in2025(₹crore) (Calendaryear) (Calendaryear) Total 17199.40 18912.64Thesales value isbased onPrice-to-Retailer (PTR)ascaptured by Pharamarack. There is no conclusive data available in the country to establish direct correlation of death/ disease exclusively due to air pollution. Air pollution is one of the triggering factors for respiratory ailments andassociated diseases. Health effects of air pollution are synergistic manifestationof factorswhich include food habits, occupationalhabits, socioeconomic status, medicalhistory, immunity, heredity, etc.of the individuals. Indian Council of Medical Research (ICMR) has informed that it has conducted a multisite study to document acute effect of increase in air pollution on respiratory morbidity. It was conducted at 5 sites. A total 33,213 (12.6%) of total Emergency Room patients were eligible and were enrolled with complete data collection. Analysis suggests that increase in pollution levels was associated with increase in number of patients attending emergency rooms. However, thisstudy design cannotprovide confirmationthat the association iscausal. The National Centre for Disease Control (NCDC) conducts sentinel surveillance of Air Pollution related illnesses through the network of more than 230 sentinel surveillance sites spanning across 30 States/UTs. Acute Respiratory Infection (ARI) digital surveillance was started inAugust 2023through IntegratedHealth InformationPortal(IHIP). *******

Continue your research